Prescription drug prices continue to rise, threatening to make vital therapies unaffordable for many patients. Kaiser Permanente believes it is time for a new legal and policy landscape for drug pricing that rewards innovation and discovery, but also provides medicines at prices patients and the health care system can afford.
This forum brought together leaders from across sectors together in Washington, D.C. to discuss the drug pricing landscape and elevate effective policy solutions.